{"DataElement":{"publicId":"2867135","version":"1","preferredName":"Eastern Cooperative Oncology Group Oncotype DX Breast Cancer Assay Outcome Stratification Type","preferredDefinition":"the ECOG, a cooperative group funded primarily by the NCI, one of the largest clinical cancer research organizations in the US, incorporating universities, medical centers, Community Clinical Oncology Programs, and Cooperative Group Outreach Programs with almost 6000 physicians, nurses, pharmacists, statisticians, and clinical research associates from the US, Canada, and South Africa, stratification type, classifying patients into strata as part of the randomization process or for purposes of data analysis, based on recurrence score for Oncotype DX breast cancer assay, a diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer._the type of recurrence score stratification.","longName":"2867124v1.0:2867127v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2867124","version":"1","preferredName":"Eastern Cooperative Oncology Group Oncotype DX Breast Cancer Assay Outcome Stratification","preferredDefinition":"information related the ECOG, a cooperative group funded primarily by the NCI, one of the largest clinical cancer research organizations in the US, incorporating universities, medical centers, Community Clinical Oncology Programs, and Cooperative Group Outreach Programs with almost 6000 physicians, nurses, pharmacists, statisticians, and clinical research associates from the US, Canada, and South Africa, stratification, of classifying patients into strata as part of the randomization process or for purposes of data analysis, based on recurrence score for Oncotype DX breast cancer assay, a diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer.","longName":"2764912v1.0:2867122v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2764912","version":"1","preferredName":"Eastern Cooperative Oncology Group","preferredDefinition":"The Eastern Cooperative Oncology Group (ECOG) was established in 1955. This is a cooperative group (Philadelphia, PA) funded primarily by the NCI, one of the largest clinical cancer research organizations in the US, incorporating universities, medical centers, Community Clinical Oncology Programs, and Cooperative Group Outreach Programs with almost 6000 physicians, nurses, pharmacists, statisticians, and clinical research associates from the US, Canada, and South Africa. ECOG has more than 90 active clinical trials in all types of adult malignancies. Annual accrual is 6,000 patients, with more than 20,000 patients in follow-up.","longName":"C25491","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Eastern Cooperative Oncology Group","conceptCode":"C25491","definition":"A cooperative group funded primarily by the NCI, one of the largest clinical cancer research organizations in the US, incorporating universities, medical centers, Community Clinical Oncology Programs, and Cooperative Group Outreach Programs with almost 6000 physicians, nurses, pharmacists, statisticians, and clinical research associates from the US, Canada, and South Africa. ECOG has more than 90 active clinical trials in all types of adult malignancies. Annual accrual is 6,000 patients, with more than 20,000 patients in follow-up.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"51AC3C52-D31A-0EAB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-07-10","modifiedBy":"ONEDATA","dateModified":"2008-07-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2867122","version":"1","preferredName":"Oncotype DX Breast Cancer Assay Outcome Stratification","preferredDefinition":"Oncotype DX is a diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition to predicting distant disease recurrence, Oncotype DX also assesses the benefit from certain types of chemotherapy. The assay, performed using formalin-fixed, paraffin-embedded tumor tissue, analyzes the expression of a panel of 21 genes and the results are provided as a Recurrence Score (0-100). The gene panel was selected and the Recurrence Score calculation was derived through extensive laboratory testing and multiple independent clinical development studies. Oncotype DX is validated for use in breast cancer patients whose disease is newly diagnosed, stage I or II, node-negative, estrogen receptor-positive and who will be treated with tamoxifen. (from genomichealth.com):Outcome; a phenomenon that follows and is caused by some previous phenomenon.:The process of classifying patients into strata as part of the randomization process or for purposes of data analysis.","longName":"C52159:C20200:C25689","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oncotype DX Breast Cancer Assay","conceptCode":"C52159","definition":"A diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition to predicting distant disease recurrence, Oncotype DX also assesses the benefit from certain types of chemotherapy. The assay, performed using formalin-fixed, paraffin-embedded tumor tissue, analyzes the expression of a panel of 21 genes and the results are provided as a Recurrence Score (0-100). The gene panel was selected and the Recurrence Score calculation was derived through extensive laboratory testing and multiple independent clinical development studies. Oncotype DX is validated for use in breast cancer patients whose disease is newly diagnosed, stage I or II, node-negative, estrogen receptor-positive and who will be treated with tamoxifen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stratification","conceptCode":"C25689","definition":"The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6918941C-442D-97EB-E040-BB89AD4347C4","latestVersionIndicator":"Yes","beginDate":"2009-05-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-05-04","modifiedBy":"ONEDATA","dateModified":"2009-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6918941C-443E-97EB-E040-BB89AD4347C4","latestVersionIndicator":"Yes","beginDate":"2009-05-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-05-04","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"**Laboratory Clean-Up**","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2867127","version":"1","preferredName":"Recurrence Score StratificationType","preferredDefinition":"the type of recurrence score stratification.","longName":"2867127v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"45","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not applicable - patient is being registered to Arm A or Arm D","valueDescription":"Not applicable - patient is being registered to Arm A or Arm D","ValueMeaning":{"publicId":"2867128","version":"1","preferredName":"Not applicable - patient is being registered to Arm A or Arm D","longName":"2867128","preferredDefinition":"Not applicable - patient is being registered to Arm A or Arm D","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6918941C-447E-97EB-E040-BB89AD4347C4","latestVersionIndicator":"Yes","beginDate":"2009-05-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-05-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6918941C-4497-97EB-E040-BB89AD4347C4","beginDate":"2009-05-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-05-04","modifiedBy":"ONEDATA","dateModified":"2009-05-04","deletedIndicator":"No"},{"value":"Twenty one to twenty five","valueDescription":"Recurrence score of 21 to 25.","ValueMeaning":{"publicId":"2867129","version":"1","preferredName":"Recurrence score of 21 to 25.","longName":"2867129","preferredDefinition":"Recurrence score of 21 to 25.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6918941C-44A1-97EB-E040-BB89AD4347C4","latestVersionIndicator":"Yes","beginDate":"2009-05-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-05-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6918941C-44BA-97EB-E040-BB89AD4347C4","beginDate":"2009-05-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-05-04","modifiedBy":"ONEDATA","dateModified":"2009-05-04","deletedIndicator":"No"},{"value":"Sixteen to twenty","valueDescription":"Recurrence score of 16 to 20.","ValueMeaning":{"publicId":"2867130","version":"1","preferredName":"Recurrence score of 16 to 20.","longName":"2867130","preferredDefinition":"Recurrence score of 16 to 20.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6918941C-44C4-97EB-E040-BB89AD4347C4","latestVersionIndicator":"Yes","beginDate":"2009-05-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-05-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6918941C-44DD-97EB-E040-BB89AD4347C4","beginDate":"2009-05-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-05-04","modifiedBy":"ONEDATA","dateModified":"2009-05-04","deletedIndicator":"No"},{"value":"Eleven to fifteen","valueDescription":"Recurrence score of 11 to 15.","ValueMeaning":{"publicId":"2867131","version":"1","preferredName":"Recurrence score of 11 to 15.","longName":"2867131","preferredDefinition":"Recurrence score of 11 to 15.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6918941C-44E7-97EB-E040-BB89AD4347C4","latestVersionIndicator":"Yes","beginDate":"2009-05-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-05-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6918941C-4500-97EB-E040-BB89AD4347C4","beginDate":"2009-05-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-05-04","modifiedBy":"ONEDATA","dateModified":"2009-05-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6918941C-4469-97EB-E040-BB89AD4347C4","latestVersionIndicator":"Yes","beginDate":"2009-05-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-05-04","modifiedBy":"CAMPBELB","dateModified":"2009-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"The ECOG Randomization will u","type":"Preferred Question Text","description":"The ECOG Randomization will use the RS score to stratify patients into the following ranges","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6918941C-453B-97EB-E040-BB89AD4347C4","latestVersionIndicator":"Yes","beginDate":"2009-05-04","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-05-04","modifiedBy":"CAMPBELB","dateModified":"2009-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}